ResMed (NYSE:RMD) Stock Price Down 3% Following Analyst Downgrade
ResMed Inc. (NYSE:RMD – Get Free Report)’s share price fell 3% during mid-day trading on Monday after Oppenheimer lowered their price target on the stock from $205.00 to $200.00. Oppenheimer currently has an outperform rating on the stock. ResMed traded as low as $210.20 and last traded at $211.61. 322,132 shares traded hands during mid-day […]